A Randomized Clinical Trial of Laparoscopic Roux-en-Y Gastric Bypass and Sleeve Gastrectomy for the Treatment of Morbid Obesity in China: a 5-Year Outcome
Autor: | Xiangyu Sun, Zhanguo Cao, Yong Zhang, Hong-Zhi Zhao, Mingfang Qin, Sanyuan Hu, Wang Cai, Chen Zhang, Rong Liu |
---|---|
Rok vydání: | 2014 |
Předmět: |
Adult
Male China medicine.medical_specialty Sleeve gastrectomy Gastroplasty Endocrinology Diabetes and Metabolism medicine.medical_treatment Gastric Bypass Comorbidity Body Mass Index law.invention Young Adult Quality of life Randomized controlled trial Gastrectomy Weight loss law Weight Loss medicine Humans Laparoscopy Postoperative Care Nutrition and Dietetics medicine.diagnostic_test business.industry Mortality rate Middle Aged Roux-en-Y anastomosis Obesity Morbid Surgery Treatment Outcome Quality of Life Female medicine.symptom business Body mass index |
Zdroj: | Obesity Surgery. 24:1617-1624 |
ISSN: | 1708-0428 0960-8923 |
DOI: | 10.1007/s11695-014-1258-2 |
Popis: | No randomized comparative trials have presented long-term outcomes for laparoscopic sleeve gastrectomy (LSG) and laparoscopic Roux-en-Y gastric bypass (LRYGB). The present study was designed to compare the efficacy and safety of these two procedures. From January 2007 to July 2008, 64 eligible patients were randomly assigned to LSG or LRYGB. During the 5-year follow-up, we compared morbidity rate, body mass index (BMI), percent of excess weight loss (%EWL), Moorehead-Ardelt (M-A) II quality of life, and resolution or improvement rate of obesity-related comorbidities between the groups. Both groups were matched with respect to age, gender, and BMI. Slightly more major complications were observed in patients undergoing LRYGB (P > 0.05). Weight loss was significantly better with LRYGB except during the first postoperative year. At 5 years, %EWL for LSG and LRYGB was 63.2 ± 24.5 % and 76.2 ± 21.7 % (P = 0.02), respectively. No statistical difference was observed in quality of life between the groups at all intervals (P > 0.05). At the last follow-up, most comorbidities in both groups were resolved or improved, with no difference between the groups (P > 0.05). LRYGB and LSG are equally safe and effective in quality of life and improvement or resolution of comorbidities, and LRYGB possesses the superiority in terms of weight loss. Further studies are needed to evaluate micronutrient deficiencies of these procedures. |
Databáze: | OpenAIRE |
Externí odkaz: |